Aenitis

Spin-off resulting from the work of the CNRS and the ESPCI Paris’ research laboratory, Aenitis Technologies, created in July 2014, is developing innovative separation, manipulation and filtration of biological elements solutions, based on acoustophoresis technologies.

Aenitis Technologies aims to become a world leader in filtering / separating solutions by acoustophoresis in three markets:

> Separation / preparation of blood labile products (platelets) from blood donation, named Blood cell processing,
> The preparation of cells from tissue and organ donations,
> The manipulation of cells such as stem cells.